Osteosarcoma treatment - where do we stand? A state of the art review.
Cancer Treatment Reviews.
Times cited: 202
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 150